Crossmark

mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells

Crossref DOI link: https://doi.org/10.1007/s10495-016-1275-9

Published Online: 2016-08-02

Published Print: 2016-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Berrak, Ozge

Arisan, Elif Damla

Obakan-Yerlikaya, Pinar

Coker-Gürkan, Ajda

Palavan-Unsal, Narçin
Funding

Funding for this research was provided by:

Türkiye Bilimsel ve Teknolojik Araştirma Kurumu (112T433)

Istanbul Kultur Universitesi (TR) (-)
License Information

License valid from 2016-08-02